| 1 | AVP, ENO2
|
| Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome.
|
| Kelen D, Andorka C, Szabó M, Alafuzoff A, Kaila K, Summanen M.
|
| PLoS One 12(9):e0184593. doi: 10.1371/journal.pone.0184593. eCollection 2017.
2017
|
| 2 | ALB, AVP
|
| Correlations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning.
|
| Li J, Wang JS, Xie ZX, Wang WZ, Wang L, Ma GY, Li YQ, Wang P.
|
| Genet Mol Res 14(3):10384-9. doi: 10.4238/2015.September.1.5.
2015
|
| 3 | AVP, DIR3
|
| Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin II gene.
|
| de Fost M, van Trotsenburg AS, van Santen HM, Endert E, van den Elzen C, Kamsteeg EJ, Swaab DF, Fliers E.
|
| Eur J Endocrinol 165(1):161-5. Epub 2011 Apr 15.
2011
|
| 4 | AVP
|
| Plasma copeptin, a unifying factor behind the metabolic syndrome.
|
| Enhörning S, Struck J, Wirfält E, Hedblad B, Morgenthaler NG, Melander O.
|
| J Clin Endocrinol Metab 96(7):E1065-72. Epub 2011 Apr 13.
2011
|
| 5 | AQP2, AVP, AVPR2
|
| Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinase.
|
| Nedvetsky PI, Tabor V, Tamma G, Beulshausen S, Skroblin P, Kirschner A, Mutig K, Boltzen M, Petrucci O, Vossenkämper A, Wiesner B, Bachmann S, Rosenthal W, Klussmann E.
|
| J Am Soc Nephrol 21(10):1645-56. Epub 2010 Aug 19.
2010
|
| 6 | AVP
|
| Copeptin and risk stratification in patients with acute dyspnea.
|
| Potocki M, Breidthardt T, Mueller A, Reichlin T, Socrates T, Arenja N, Reiter M, Morgenthaler NG, Bergmann A, Noveanu M, Buser PT, Mueller C.
|
| Crit Care 14(6):R213. Epub 2010 Nov 24.
2010
|
| 7 | AVP
|
| Plasma copeptin and the risk of diabetes mellitus.
|
| Enhörning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton-Cheh C, Melander O.
|
| Circulation 121(19):2102-8. Epub 2010 May 3.
2010
|
| 8 | AQP2, AVP
|
| Regulation of aquaporin-2 trafficking.
|
| Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E.
|
| Handb Exp Pharmacol (190):133-57. Review.
2009
|
| 9 | AVP
|
| Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.
|
| Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH Jr, Kullo IJ.
|
| J Clin Endocrinol Metab 94(7):2558-64. Epub 2009 Apr 14.
2009
|
| 10 | AVP
|
| C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
|
| Kelly D, Squire IB, Khan SQ, Quinn P, Struck J, Morgenthaler NG, Davies JE, Ng LL.
|
| J Card Fail 14(9):739-45. Epub 2008 Aug 30.
2008
|
| 11 | AVP, DIR3
|
| A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
|
| Tae HJ, Baek KH, Shim SM, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK.
|
| Mol Genet Metab 86(1-2):307-13. Epub 2005 Jul 11. 2005
|
| 12 | AVP, AQP2, AKAP7
|
| Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells.
|
| Henn V, Edemir B, Stefan E, Wiesner B, Lorenz D, Theilig F, Schmitt R, Vossebein L, Tamma G, Beyermann M, Krause E, Herberg FW, Valenti G, Bachmann S, Rosenthal W, Klussmann E.
|
| J Biol Chem 279(25):26654-65. Epub 2004 Mar 22. 2004
|
| 13 | AVP, DIR3
|
| Six novel mutations in the arginine vasopressin gene in 15 kindreds with autosomal dominant familial neurohypophyseal diabetes insipidus give further insight into the pathogenesis.
|
| Christensen JH, Siggaard C, Corydon TJ, deSanctis L, Kovacs L, Robertson GL, Gregersen N, Rittig S.
|
| Eur J Hum Genet 12(1):44-51.
2004
|
| 14 | AVP, DIR3
|
| Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor.
|
| Rittig S, Siggaard C, Ozata M, Yetkin I, Gregersen N, Pedersen EB, Robertson GL.
|
| J Clin Endocrinol Metab 87(7):3351-5. 2002
|
| 15 | AVP, DIR3
|
| Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene.
|
| Fujii H, Iida S, Moriwaki K.
|
| Int J Mol Med 5(3):229-34. 2000
|
| 16 | AVP, DIR3
|
| A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
|
| Rutishauser J, et al.
|
| Mol Genet Metab 67(1):89-92. 1999
|
| 17 | AVP, DIR3
|
| Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.
|
| Willcutts MD, et al.
|
| Hum Mol Genet 8(7):1303-1307. 1999
|
| 18 | AVP, DIR3
|
| Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins.
|
| Ito M, et al.
|
| J Biol Chem 274(13):9029-37. 1999
|
| 19 | AVP, DIR3
|
| Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.
|
| Siggaard C, et al.
|
| J Clin Endocrinol Metab 84(8):2933-41 1999
|
| 20 | AVP, DIR3
|
| Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant.
|
| Grant FD, Ahmadi A, Hosley CM, Majzoub JA.
|
| J Clin Endocrinol Metab 83 : 3958-3964. 1998
|
| 21 | AVP, DIR3
|
| Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
|
| Repaske DR, et al.
|
| J Clin Endocrinol Metab 82 : 51-56. 1997
|
| 22 | AVP, DIR3
|
| Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II.
|
| Gagliardi PC, Bernasconi S, Repaske DR.
|
| J Clin Endocrinol Metab 82(11):3643-6. 1997
|
| 23 | AVP, DIR3
|
| Idenditification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus.
|
| Rittig S, et al.
|
| Am J Hum Genet 58 : 107-117. 1996
|
| 24 | AVP, DIR3
|
| A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene : cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.
|
| Rutishauser J, et al.
|
| J Clin Endocrinol Metab 81 : 192-198. 1996
|
| 25 | AVP, DIR3
|
| A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene.
|
| Ueta Y, et al.
|
| J Clin Endocrinol Metab 81 : 1787-1790. 1996
|
| 26 | AVP, DIR3
|
| Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus.
|
| Repaske DR, et al.
|
| J Clin Endocrinol Metab 81 : 2328-2334. 1996
|
| 27 | AVP, DIR3
|
| Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus.
|
| Nagasaki H, et al.
|
| J Clin Endocrinol Metab 80 : 1352-1356. 1995
|
| 28 | AVP, DIR3
|
| Recurring dominant-negative mutations in the AVP-NPII gene cause neurohypophyseal diabetes insipidus. (abstr)
|
| Repaske DR, et al.
|
| Am J Hum Genet 55 : A239. 1994
|
| 29 | AVP, DIR3
|
| A De novo mutation in the coding sequence for neurophysin-II (Pro24-Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus.
|
| Repaske DR, et al.
|
| J Clin Endocrinol Metab 79 : 421-427. 1994
|
| 30 | AVP, DIR3
|
| Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.
|
| McLeod JF, et al.
|
| J Clin Endocrinol Metab 77 : 599A-599G. 1993
|
| 31 | AVP, DIR3
|
| Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.
|
| Ito M, et al.
|
| J Clin Invest 91 : 2565-2571. 1993
|
| 32 | AVP, DIR3
|
| A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus.
|
| Bahnsen U, et al.
|
| EMBO J 11 : 19-23. 1992
|
| 33 | AVP, DIR3
|
| A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.
|
| Ito M, et al.
|
| J Clin Invest 87 : 725-728. 1991
|
| 34 | AVP, DIR3
|
| Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus.
|
| Repaske DR, et al.
|
| J Clin Endocrinol Metab 70 : 752-757. 1990
|
| 35 | AVP, GHRH
|
| Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor.
|
| Riddell DC, et al.
|
| Somat Cell Mol Genet 11 : 189-195. 1985
|